Page last updated: 2024-10-30

mesalamine and Epstein-Barr Virus Infections

mesalamine has been researched along with Epstein-Barr Virus Infections in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Epstein-Barr Virus Infections: Infection with human herpesvirus 4 (HERPESVIRUS 4, HUMAN); which may facilitate the development of various lymphoproliferative disorders. These include BURKITT LYMPHOMA (African type), INFECTIOUS MONONUCLEOSIS, and oral hairy leukoplakia (LEUKOPLAKIA, HAIRY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Magro, F1
Santos-Antunes, J1
Albuquerque, A1
Vilas-Boas, F1
Macedo, GN1
Nazareth, N1
Lopes, S1
Sobrinho-Simões, J1
Teixeira, S1
Dias, CC1
Cabral, J1
Sarmento, A1
Macedo, G1

Other Studies

1 other study available for mesalamine and Epstein-Barr Virus Infections

ArticleYear
Epstein-Barr virus in inflammatory bowel disease-correlation with different therapeutic regimens.
    Inflammatory bowel diseases, 2013, Volume: 19, Issue:8

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Azathioprine; Case-Control S

2013